1[1]Wei CM,Gibson M,Spear PG,et al.Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1[J].J Virol,1981,39:935～944. 被引量：1
2[2]Shimotohno K,Temin HM.Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus [J].Cell,1981,26:67～77. 被引量：1
3[3]Lewis PF,Emerman M.Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus [J].J Virol,1994,68:510～516. 被引量：1
4[4]Miller DG,Adam MA,Miller AD.Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection [J].Mol Cell Biol,1994,10:4239～4242. 被引量：1
5[5]Barzon L,Bonaguro R,Castagliuolo I,et al.Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase[J].Eur J Endocrinol,2003,148:73～80. 被引量：1
6[6]Heise C,Hermiston T,Johnson L,et al.An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy [J].Nat Med,2000,6:1134～1139. 被引量：1
8[8]Parker JN,Gillespie GY,Love CE,et al.Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors [J].Proc Natl Acad Sci USA,2000,97:2208～2213. 被引量：1
9[9]Stevenson AF,Frolova-Jones E,Hall KT,et al.A herpes virus saimiri-based gene therapy vector with potential for use in cancer immunotherapy [J].Cancer Gene Ther,2000,7 (7):1077～1085. 被引量：1
10[10]Latchman DS.Gene delivery and gene therapy with herpes simplex virus-based vectors [J].Gene,2001,264:1～9. 被引量：1
10LaMontagne KR Jr, Flint A J, Robert FB, et al. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr/abl in vivo [J]. Mol Cell Biol, 1998, 18(5) :2965-2975. 被引量：1
